Unknown

Dataset Information

Methadone Use and the Risk of Hypoglycemia for Inpatients With Cancer Pain.


ABSTRACT:

Context

Methadone is an important drug in the management of both cancer-related and non-cancer-related pain and is the main pharmacologic agent used in the treatment of opioid addiction. Unexpected hypoglycemia has been observed in patients receiving methadone, prompting a more detailed investigation.

Objectives

To evaluate the incidence of hypoglycemia in a cohort of inpatients receiving methadone versus other opioids including fentanyl, hydromorphone, and morphine.

Methods

Retrospective observational cohort of inpatients in a tertiary cancer center admitted for more than 48 hours from November 1, 2011 to October 30, 2013. The main outcomes were lowest measured daily blood glucose (in mg/dL) and incidence of hypoglycemia (defined as blood glucose < 70 mg/dL, equivale

SUBMITTER: Flory JH 

PROVIDER: S-EPMC5484401 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature